|
PPP2R5C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.08615372041277E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.19919646329936E-11 |
| Normal-vs-Stage2 |
1.991630E-04 |
| Normal-vs-Stage3 |
7.45890016418116E-11 |
| Normal-vs-Stage4 |
3.6331000430323E-09 |
| Stage1-vs-Stage2 |
4.336000E-01 |
| Stage1-vs-Stage3 |
4.403200E-01 |
| Stage1-vs-Stage4 |
2.753400E-01 |
| Stage2-vs-Stage3 |
2.282600E-01 |
| Stage2-vs-Stage4 |
1.643420E-01 |
| Stage3-vs-Stage4 |
6.363400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.08895139969445E-13 |
| Normal-vs-AfricanAmerican |
1.168100E-02 |
| Normal-vs-Asian |
1.77530001810311E-09 |
| Caucasian-vs-AfricanAmerican |
1.122810E-01 |
| Caucasian-vs-Asian |
9.719000E-01 |
| AfricanAmerican-vs-Asian |
1.718410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.27709999534432E-08 |
| Normal-vs-Female |
2.85094170493494E-12 |
| Male-vs-Female |
1.104990E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.49330009363769E-10 |
| Normal-vs-Age(41-60Yrs) |
3.29303251334068E-12 |
| Normal-vs-Age(61-80Yrs) |
4.11260003829739E-09 |
| Normal-vs-Age(81-100Yrs) |
1.375890E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.488000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.236600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.525800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.685400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.559600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.016200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.021700E-02 |
| Classical-VS-Follicular |
1.006340E-02 |
| Classical-VS-Other |
1.394620E-01 |
| Classical-VS-Normal |
5.30010035859618E-10 |
| Tall-VS-Follicular |
1.996650E-04 |
| Tall-VS-Other |
4.420600E-01 |
| Tall-VS-Normal |
6.88109569324524E-11 |
| Follicular-VS-Other |
5.983300E-03 |
| Follicular-VS-Normal |
4.200100E-04 |
| Other-VS-Normal |
1.48410000000432E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.21549445456048E-11 |
| Normal-vs-N1 |
1.20940000236658E-08 |
| N0-vs-N1 |
2.402200E-01 |
|
|
